48,702
edits
Difference between revisions of "Medical lung diseases"
Jump to navigation
Jump to search
→Lymphangioleiomyomatosis: more
m (→General: wikify) |
(→Lymphangioleiomyomatosis: more) |
||
| Line 557: | Line 557: | ||
==Lymphangioleiomyomatosis== | ==Lymphangioleiomyomatosis== | ||
*Abbreviated ''LAM''. | |||
*[[AKA]] lymphangiomyomatosis. | |||
===General=== | ===General=== | ||
*Clinical: dyspnea, recurrent pneumothorax. | *Clinical: dyspnea, recurrent pneumothorax. | ||
*May be an indication for lung transplantation. | *May be an indication for lung transplantation. | ||
*Non-neoplastic muscle proliferation vs. tumour that can metastasize.<ref name=pmid20235883>{{Cite journal | last1 = Taveira-DaSilva | first1 = AM. | last2 = Pacheco-Rodriguez | first2 = G. | last3 = Moss | first3 = J. | title = The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. | journal = Lymphat Res Biol | volume = 8 | issue = 1 | pages = 9-19 | month = Mar | year = 2010 | doi = 10.1089/lrb.2009.0024 | PMID = 20235883 }}</ref> | *Non-neoplastic muscle proliferation vs. tumour that can metastasize.<ref name=pmid20235883>{{Cite journal | last1 = Taveira-DaSilva | first1 = AM. | last2 = Pacheco-Rodriguez | first2 = G. | last3 = Moss | first3 = J. | title = The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis. | journal = Lymphat Res Biol | volume = 8 | issue = 1 | pages = 9-19 | month = Mar | year = 2010 | doi = 10.1089/lrb.2009.0024 | PMID = 20235883 }}</ref> | ||
Notes: | |||
*Considered to be a [[PEComa]]. | |||
===Epidemiology=== | ===Epidemiology=== | ||